IL6 and lung carcinoma: In contrast, OSM and IL-6 are expressed in breast, prostate, and lung cancer cell lines, and promote tumor development by modulating lipid metabolism, matrix degradation, angiogenesis, and cellular dedifferentiation [45, 46].